ArticleEuropean journal of medical research2025
Analysis of the short-to-intermediate-term efficacy of autologous costochondral transplantation in treatment for Hepple V osteochondral lesion of talus.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectivesTo analyze the feasibility, effectiveness and safety of autologous costochondral transplantation (ACT) in patients with Hepple V osteochondral lesion of talus (OLT), and to analyze the short-to-intermediate-term efficacy.
methodsClinical data of 27 patients (27 ankles) with Hepple V OLT admitted in Shanghai Jiao Tong University School of Medicine Affiliated Sixth People's Hospital between February 2020 and February 2022 were retrospectively analyzed, of which were treated with ACT. The general information, operation time, and hospitalization days of the patients were recorded. According to the foot and ankle ability measurement (FAAM)-activities of daily living subscale (FAAM-ADL) and sports subscale (FAAM-Sp), the EuroQol-Visual Analogue Scale (EQ VAS) and the Magnetic Resonance Observation of Cartilage Repair Tissue 2.0 ankle score (MOCART 2.0), surgical efficacy and of the patients' function were evaluated, to verify the clinical satisfaction of ACT. The related complications that occurred during the follow-up of the patients in the group were also recorded. Statistical analysis included normality assessment, intra-group comparisons (one-way analysis of variance (ANOVA) and LSD method for normal quantitative data, Mann-Whitney U for non-normal data, and chi-square for categorical variables). P < 0.05 was considered a statistically significant difference.
resultsAll patients were operated successfully. The general information, operation time, and hospitalization days of the patients were fully recorded. At the final follow-up, scores of FAAM-ADL, FAAM-Sp and EQ VAS were improved to 87.7 ± 6.8 (P < 0.001), 87.2 ± 7.4 (P < 0.001), 90.7 ± 3.3 (P < 0.001) from preoperative ones, respectively. MOCART 2.0 scores improved from 85(80, 90) 12 months postoperatively to 85(85, 90) at final follow-up (P = 0.025). Three patients (11.1%) voluntarily removed the internal fixation of the internal ankle osteotomy. There were no complications, such as neurovascular injury, nonunion or delayed union, and post-traumatic arthritis in both groups.
conclusionThis study preliminarily validated that ACT could restore the defective talar articular cartilage shorten the operation time and hospitalization days, reduce the amount of intraoperative blood loss, achieve excellent outcomes and help patients return to work and recreational activities more quickly.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.